Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05281159 · ClinicalTrials.gov registry record · NA
Increasing Engagement With Messages Regarding CRC Screening Among Adults Aged 45-49
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 20,509
- Enrollment target
NCT05281159 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 20,509 participants.
The verdict
NCT05281159, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,509 participants
- Enrollment target
Study Summary
In May of 2021, the United States Preventive Service Task Force (USPSTF) updated their colorectal cancer (CRC) screening guidelines by recommending screening at an earlier age for average-risk adults starting at the age of 45 years old (Grade B recommendation). This is in addition to their Grade A recommendations of continuing to screen average-risk adults ages 50-75 years old. As the investigators health system aims to screen the newly eligible population of average-risk patients between the ages of 45-49, the investigators proposed randomized controlled trial is aimed to determine the most effective patient outreach approach to increase patients' engagement with messages regarding CRC screening and screening uptake within this specific age-group.
Interventions
- BEHAVIORAL Risk Information
- BEHAVIORAL Risk Information + Action
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,509 participants |
| Start Date | 2022-02-21 |
| Est. Completion | 2022-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05281159
The ClinicalTrials.gov registry entry for NCT05281159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20,509 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Risk Information is the first listed.
NCT05281159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05281159 about?
NCT05281159 is a clinical study titled "Increasing Engagement With Messages Regarding CRC Screening Among Adults Aged 45-49". In May of 2021, the United States Preventive Service Task Force (USPSTF) updated their colorectal cancer (CRC) screening guidelines by recommending screening at an earlier age for average-risk adults starting at the age of 45 years old (Grade B recommendation). This is in addition to their Grade A r...
What is the current status of trial NCT05281159?
This trial is currently completed. It is a NA study. The enrollment target is 20,509 participants. The study started on 2022-02-21. Estimated completion is 2022-11-21.
What interventions are being tested in trial NCT05281159?
The interventions under investigation include: Risk Information (BEHAVIORAL), Risk Information + Action (BEHAVIORAL).
Who is sponsoring clinical trial NCT05281159?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.